Angela Genge, MD, FRCP(C)
Dr. Angela Genge has been the Director of the Amyotrophic Lateral Sclerosis (ALS) clinic at The Neuro (Montreal Neurological Institute-Hospital) since 1998 as well as the Executive Director of The Neuro’s Clinical Research Unit (CRU) since 2004. She is an international leader in clinical trial design and development for rare neurological conditions with an emphasis on ALS and motor neuron disease (MND). She sits on a number of advisory boards as well as data and safety monitoring boards.
Newfoundland-born, Dr. Angela Genge completed her medical degree at the Memorial University of Newfoundland. She obtained her Canadian and American certifications in Internal Medicine and Neurology prior to completing a fellowship in neuromuscular diseases at The Neuro, assisting Dr. Gordon Francis, the founder of the Clinical Research Unit.
Under Dr. Genge’s direction, the CRU has grown to become one of the largest neurological clinical research centres in Canada, home to a first-of-its-kind Phase 1 Unit dedicated to neurological diseases, as well as an ALS Global Center of Excellence in Patient Care.
She is the recipient of the 2018 Forbes Norris Award from the International Alliance for ALS/MND, the YMCA Woman of the Year Award and the Governor General Diamond Jubilee Award among other awards for exceptional patient care and the management of ALS studies.
